Ethosuximide
Product Images NDC 68382-443

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ethosuximide (NDC 68382-443). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Ethosuximide (Ethosuximidecapsules Figure 01)

Chemical structure of ethosuximide, showing its molecular arrangement with functional groups and bond connectivity as depicted in the image.*

FDA Label Image

Structured Formula For Ethosuximide-250mg (Ethosuximidecapsules Figure 02)

Label for ethosuximide capsules, USP, 250 mg, by Zydus Pharmaceuticals (USA) Inc. The label displays the NDC 68382-443-01 and specifies a bottle containing 100 capsules. The label includes dosing guidance, storage instructions, and manufacturer and distributor details. It is marked Rx only and includes lot and expiration information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.